Jet transport performance in thunderstorm wind shear conditions

Several hours of three dimensional wind data were collected in the thunderstorm approach-to-landing environment, using an instrumented Queen Air airplane. These data were used as input to a numerical simulation of aircraft response, concentrating on fixed-stick assumptions, while the aircraft simulated an instrument landing systems approach. Output included airspeed, vertical displacement, pitch angle, and a special approach deterioration parameter. Theory and the results of approximately 1000 simulations indicated that about 20 percent of the cases contained serious wind shear conditions capable of causing a critical deterioration of the approach. In particular, the presence of high energy at the airplane's phugoid frequency was found to have a deleterious effect on approach quality. Oscillations of the horizontal wind at the phugoid frequency were found to have a more serious effect than vertical wind. A simulation of Eastern flight 66, which crashed at JFK in 1975, served to illustrate the points of the research. A concept of a real-time wind shear detector was outlined utilizing these results

SWAS observations of comet 9P/Tempel 1 and Deep Impact

On 4 July 2005 at 1:52 UT the Deep Impact mission successfully completed its goal to hit the nucleus of 9P/Tempel 1 with an impactor, forming a crater on the nucleus and ejecting material into the coma of the comet. The 370 kg impactor collided with the sunlit side of the nucleus with a relative velocity of 10.2 km/s. NASA's Submillimeter Wave Astronomy Satellite (SWAS) observed the 1(10)-1(01) ortho-water ground-state rotational transition in comet 9P/Tempel 1 before, during, and after the impact. No excess emission from the impact was detected by SWAS. However, the water production rate of the comet showed large natural variations of more than a factor of three during the weeks before the impact.Comment: to appear in the proceedings of the IAU Symposium No. 231: "Astrochemistry - Recent Successes and Current Callenges". Typo corrected in author affiliation lis

Safety and Efficacy of Extended Interval Dosing for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer During the COVID-19 Pandemic

INTRODUCTION: Extended interval (EI) dosing for immune checkpoint inhibitor (ICI) mono- or consolidation therapy initiated due to the COVID-19 pandemic led to a significant reduction in ICI-related site visits for patients with stage III and IV non-small cell lung cancer (NSCLC). Here we report the safety and efficacy compared to standard dose (SD) schedules. METHOD: In this retrospective analysis patients who received ICI mono- or consolidation therapy, or adjuvant ICI therapy were assessed. Safety and efficacy of EI dosing with data of SD schedules were compared. RESULTS: One hundred seventeen patients received EI dosing for ICI and 88 patients SD. Patient characteristics were comparable. We observed 237 adverse events in the EI dosing cohort versus 118 in the SD group (p = 0.02). Overall, there was no difference in the occurrence of grade ≥3 adverse events (EI dosing: 21/237 [8.9%]; SD group: 20/118 [17.0%], p = 0.42), except for the pembrolizumab EI dosing cohort. Of all patients who received an EI dosing schedule, however, only 8 (6.8%) were reduced to SD because of toxicity. In 5 (4.3%) patients ICI was permanently stopped because of severe toxicity compared to 11 (12.5%) discontinuations in the SD group. Short-term treatment interruption occurred with similar frequencies in both groups. PFS and OS were comparable in patients receiving pembrolizumab and in those receiving adjuvant durvalumab. Progression-free survival and OS were better in the EI dosing cohort of nivolumab. CONCLUSION: EI dosing for ICI did not lead to an increase of clinically relevant toxicities resulting in dose reduction and/or treatment discontinuation. Efficacy of EI dosing of pembrolizumab and durvalumab were comparable to SD. Based on our safety and efficacy data EI dosing for ICI seems a safe and effective strategy. MICRO ABSTRACT: Aim Retrospective analysis of the safety and efficacy of extended interval dosing (EI) ICI compared to standard dose (SD) schedules. Results 117 patients received EI dosing and 88 SD. In the EI dosing cohort was no increase in toxicity leading to dose reduction and/or discontinuation of treatment. Furthermore, efficacy of EI dosing of pembrolizumab and durvalumab were comparable to SD. Based on our safety and efficacy data EI dosing for ICI seem a safe and effective strategy and should be continued also beyond the COVID-19 pandemic

Phosphorus donors in highly strained silicon

The hyperfine interaction of phosphorus donors in fully strained Si thin films grown on virtual Si$_{1-x}$Ge$_x$ substrates with $x\leq 0.3$ is determined via electrically detected magnetic resonance. For highly strained epilayers, hyperfine interactions as low as 0.8 mT are observed, significantly below the limit predicted by valley repopulation. Within a Green's function approach, density functional theory (DFT) shows that the additional reduction is caused by the volume increase of the unit cell and a local relaxation of the Si ligands of the P donor.Comment: 12 pages, 3 figure